Maxim Group analyst Jason Kolbert maintained a Buy rating on OncoSec Medical (OTC:ONCS) with a price target of $3.00, as the company announced a …
In a research report sent to investors today, H.C.
In a research report published today, H.C.
In a research note released today, Maxim Group analyst Jason Kolbert reaffirmed a Buy rating on OncoSec Medical (OTC:ONCS) with a $3 price …
In a research note published today, H.C.
In a research note issued this morning, H.C.
